ArticleBiotechnology for biofuels2013
Bioelectricity versus bioethanol from sugarcane bagasse: is it worth being flexible?
Article in Biotechnology for biofuels, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 119 citations in OpenAlex.
- A panoramic view of technological landscape for bioethanol production from various generations of feedstocks.Bioengineered · 2023Review
- Assessment of Coproduction of Ethanol and Methane fromACS sustainable chemistry & engineering · 2021Article
- Obtaining hemicellulosic hydrolysate from sugarcane bagasse for microbial oil production by Lipomyces starkeyi.Biotechnology letters · 2021Article
- Revisiting Meiosis in Sugarcane: Chromosomal Irregularities and the Prevalence of Bivalent Configurations.Frontiers in genetics · 2018Article
- Combined ensiling and hydrothermal processing as efficient pretreatment of sugarcane bagasse for 2G bioethanol production.Biotechnology for biofuels · 2018Article
- 2G ethanol from the whole sugarcane lignocellulosic biomass.Biotechnology for biofuels · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSugarcane is the most efficient crop for production of (1G) ethanol. Additionally, sugarcane bagasse can be used to produce (2G) ethanol. However, the manufacture of 2G ethanol in large scale is not a consolidated process yet. Thus, a detailed economic analysis, based on consistent simulations of the process, is worthwhile. Moreover, both ethanol and electric energy markets have been extremely volatile in Brazil, which suggests that a flexible biorefinery, able to switch between 2G ethanol and electric energy production, could be an option to absorb fluctuations in relative prices. Simulations of three cases were run using the software EMSO: production of 1G ethanol + electric energy, of 1G + 2G ethanol and a flexible biorefinery. Bagasse for 2G ethanol was pretreated with a weak acid solution, followed by enzymatic hydrolysis, while 50% of sugarcane trash (mostly leaves) was used as surplus fuel.
resultsWith maximum diversion of bagasse to 2G ethanol (74% of the total), an increase of 25.8% in ethanol production (reaching 115.2 L/tonne of sugarcane) was achieved. An increase of 21.1% in the current ethanol price would be enough to make all three biorefineries economically viable (11.5% for the 1G + 2G dedicated biorefinery). For 2012 prices, the flexible biorefinery presented a lower Internal Rate of Return (IRR) than the 1G + 2G dedicated biorefinery. The impact of electric energy prices (auction and spot market) and of enzyme costs on the IRR was not as significant as it would be expected.
conclusionsFor current market prices in Brazil, not even production of 1G bioethanol is economically feasible. However, the 1G + 2G dedicated biorefinery is closer to feasibility than the conventional 1G + electric energy industrial plant. Besides, the IRR of the 1G + 2G biorefinery is more sensitive with respect to the price of ethanol, and an increase of 11.5% in this value would be enough to achieve feasibility. The ability of the flexible biorefinery to take advantage of seasonal fluctuations does not make up for its higher investment cost, in the present scenario.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.